Skip to main content
OpenTrials

Clinical trial condition

Hemic and Lymphatic Diseases

Explore clinical trials studying Hemic and Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

21,092 public trials 3,997 recruiting studies
Refine in advanced search Browse all conditions

Hemic and Lymphatic Diseases trial results

Recruiting

AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)

NCT05850234

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Phoenix, Arizona, United States
  • Research Site La Jolla, California, United States
  • Research Site Los Angeles, California, United States
View all 36 locations
View Trial Details
Recruiting

Tranexamic Acid for Anaemia Trial

NCT06519422

Conditions
Anaemia, Anemia, Hematologic Diseases, +8 more
Locations
  • University College Hospital Ibadan, Oyo State, Nigeria
  • Shifa Tameer e Millat University Islamabad, Pakistan
  • Mbeya College of Health and Allied Sciences, University of Dar es Salaam Mbeya, Tanzania
View Trial Details
Recruiting

ALL Backbone in AYAs

NCT07227584

Conditions
Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia (ALL), Hematologic Diseases, +11 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Recruiting

A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma

NCT07323654

Conditions
Eosinophilia, Eosinophilic Asthma, Hematologic Diseases, +6 more
Locations
  • Kymera Investigative Site Lancaster, California, United States
  • Kymera Investigative Site Long Beach, California, United States
  • Kymera Investigative Site Northridge, California, United States
  • Kymera Investigative Site Redding, California, United States
View all 71 locations
View Trial Details
Recruiting

A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)

NCT07409246

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • City of Hope National Medical Center /ID# 280273 Duarte, California, United States
  • City of Hope - Orange County Lennar Foundation Cancer Center /ID# 279067 Irvine, California, United States
  • Colorado Blood Cancer Institute /ID# 280275 Denver, Colorado, United States
  • START Midwest /ID# 279035 Grand Rapids, Michigan, United States
View Trial Details
Recruiting

OSTEOMICS: Identifying Regulators of Bone Homeostasis

NCT05732870

Conditions
Arthritis, Bone Diseases, Bone Diseases, Metabolic, +14 more
Locations
  • Harley Street Specialist Hospital London, Greater London, United Kingdom
  • Barts Health NHS Trust London, United Kingdom
  • Chase Farm Hospital London, United Kingdom
  • Fitzrovia Hospital/QASMC London, United Kingdom
View Trial Details
Recruiting

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

NCT06274788

Conditions
Essential Fatty Acid Deficiency, Hematologic Diseases, Hemic and Lymphatic Diseases, +14 more
Locations
  • Memorial Health Service Fountain Valley, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • The University of Chicago Chicago, Illinois, United States
  • Children's Hospital Corporation d/b/a Boston Children's Hospital Boston, Massachusetts, United States
View Trial Details
Recruiting

Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure

NCT06651970

Conditions
Chronic Lymphocytic Leukaemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations
  • Research Site Charlotte, North Carolina, United States
  • Research Site Columbus, Ohio, United States
  • Research Site Philadelphia, Pennsylvania, United States
  • Research Site Brno, Czechia
View all 23 locations
View Trial Details

Related conditions